Clinical Trial Update: Evaluate the Safety and Potential Efficacy of Human Wharton's Jelly-derived Mesenchymal Stem Cells With Charcot-Marie-Tooth Disease Type 1E [NA]

View source ↗

Summary

This clinical trial has completed evaluating the safety and potential efficacy of human Wharton's Jelly-derived mesenchymal stem cells for Charcot-Marie-Tooth d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot-marie-tooth Disease Type 1e

Drugs mentioned

• Wharton's Jelly Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Samsung Medical Center | Conditions: Charcot-Marie-Tooth Disease, Type 1 | NA | Status: COMPLETED